01.10.06
Indication: Heart attack
Source: American Heart Association Meeting, Dallas, TX
Research: Researchers examined data compiled from 18,645 patients in a long-term studying testing the effect of eicosapentaenoic acid (EPA) plus statins versus statins alone in patients with high cholesterol. In addition to taking statins, the fish oil group received 1800 milligrams of high purified SPA in capsule form per day.
Results: Researchers found a 19% reduction in a variety of adverse heart events in the EPA-plus-statins group. The statin-only group had a 3.5% incidence of adverse events over the course of more than four-and-a-half years of follow-up study, while the EPA-plus-statins group had only a 2.8% incidence of negative heart outcomes. The adverse events included in the primary goal of the study were sudden cardiac death, heart attacks, unstable angina or chest pain, and the need to undergo procedures to reopen clogged arteries. The patients were further divided into those with histories of heart disease and those with no such history. When broken out, there was only a significant benefit from EPA demonstrated in the heart disease patients, according to researchers.
Source: American Heart Association Meeting, Dallas, TX
Research: Researchers examined data compiled from 18,645 patients in a long-term studying testing the effect of eicosapentaenoic acid (EPA) plus statins versus statins alone in patients with high cholesterol. In addition to taking statins, the fish oil group received 1800 milligrams of high purified SPA in capsule form per day.
Results: Researchers found a 19% reduction in a variety of adverse heart events in the EPA-plus-statins group. The statin-only group had a 3.5% incidence of adverse events over the course of more than four-and-a-half years of follow-up study, while the EPA-plus-statins group had only a 2.8% incidence of negative heart outcomes. The adverse events included in the primary goal of the study were sudden cardiac death, heart attacks, unstable angina or chest pain, and the need to undergo procedures to reopen clogged arteries. The patients were further divided into those with histories of heart disease and those with no such history. When broken out, there was only a significant benefit from EPA demonstrated in the heart disease patients, according to researchers.